Yamaguchi Kohsei, Saito Tetsuo, Matsuyama Tomohiko, Fukugawa Yoshiyuki, Watakabe Takahiro, Yamada Shigeo, Oya Natsuo
Department of Radiation Oncology, Ariake Medical Center 2600, Arao, Kumamoto 864-0041, Japan.
Division of Integrative Medical Oncology, Saiseikai Kumamoto Hospital 5-3-1, Chikami Minami-ku, Kumamoto 861-4193, Japan.
J Radiat Res. 2025 Sep 23;66(5):520-527. doi: 10.1093/jrr/rraf039.
The influences of tumor volume and total radiation dose on pain relief outcomes have not been fully investigated. We investigated potential correlations between gross tumor volume (GTV), biologically effective dose (BED) and pain relief in patients receiving radiation therapy (RT) for painful tumors. As a secondary analysis of a three-center prospective observational study of 302 patients who received RT for painful tumors, patients treated at an academic hospital were analyzed. We used the Brief Pain Inventory short form to evaluate pain intensity and interference in patients' lives. We collected the Brief Pain Inventory and analgesic data at baseline and 1, 2, 3, 6, 9 and 12 months after the start of RT. Pain responses were assessed using the International Consensus Endpoint. The Fine and Gray models were used for univariable and multivariable analyses, to estimate the impact of clinical factors on pain response and pain progression. In total, 153 (59%) of the 258 patients experienced a pain response, and 45 (17%) patients experienced pain progression. In the univariable and multivariable analyses, GTV and BED did not significantly associate with pain response or pain progression. Furthermore, no significant interaction between GTV and BED was reported in terms of pain response or pain progression after adjusting for covariates. The impact of BED on pain response and pain progression did not vary according to the GTV.
肿瘤体积和总辐射剂量对疼痛缓解效果的影响尚未得到充分研究。我们调查了接受疼痛性肿瘤放射治疗(RT)的患者中,大体肿瘤体积(GTV)、生物等效剂量(BED)与疼痛缓解之间的潜在相关性。作为一项对302例接受疼痛性肿瘤RT治疗患者的三中心前瞻性观察研究的二次分析,我们分析了在一所学术医院接受治疗的患者。我们使用简明疼痛问卷简表来评估患者的疼痛强度及其对生活的干扰。我们在RT开始时的基线以及之后的1、2、3、6、9和12个月收集简明疼痛问卷和镇痛数据。使用国际共识终点评估疼痛反应。采用Fine和Gray模型进行单变量和多变量分析,以估计临床因素对疼痛反应和疼痛进展的影响。在258例患者中,共有153例(59%)出现疼痛反应,45例(17%)患者出现疼痛进展。在单变量和多变量分析中,GTV和BED与疼痛反应或疼痛进展均无显著相关性。此外,在对协变量进行调整后,未报告GTV和BED在疼痛反应或疼痛进展方面存在显著交互作用。BED对疼痛反应和疼痛进展的影响并未因GTV而异。